Physician profile
Jerry Hadrych
NPI 1124010459
$5,136.72
in general payments reported to CMS, 2019-2025
20 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,300 · 2020: $191 · 2021: $211 · 2022: $1,054 · 2023: $1,031 · 2024: $253 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,400 · Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,400.01 |
| Food and Beverage | $980.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,383.18 | 2019-2025 | |
| Organogenesis INC. | $519.71 | 2019-2025 | Puraply Wound Matrix, Puraply, Via Matrix |
| Paratek Pharmaceuticals, INC. | $244.90 | 2020-2023 | Nuzyra |
| Smith+Nephew, INC. | $154.47 | 2019 | |
| Horizon Therapeutics Plc | $140.73 | 2019-2023 | Krystexxa |
| Abbott Laboratories | $130.28 | 2019-2022 | |
| Amgen INC. | $84.11 | 2024-2025 | Krystexxa |
| Cumberland Pharmaceuticals, INC. | $70.86 | 2020-2022 | |
| Kerecis Limited | $68.28 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Melinta Therapeutics, LLC | $67.29 | 2019-2022 | |
| Innovation Technologies INC | $66.81 | 2024 | Irrisept |
| Allergan, INC. | $50.21 | 2019 | |
| Stryker Corporation | $38.79 | 2022 | |
| Hartmann USA, INC. | $21.64 | 2022 | |
| Integra Lifesciences Corporation | $20.59 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $17.59 | 2019 | |
| Paragon 28, INC. | $16.77 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.22 | 2023 | Seglentis, Livalo |
| Mckesson Patient Care Solutions INC. | $12.48 | 2019 | |
| Nevro Corp. | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Hadrych listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.